Detalhe da pesquisa
1.
The Impact of Type 2 Diabetes in Parkinson's Disease.
Mov Disord
; 37(8): 1612-1623, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699244
2.
Correction to: Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
Acta Neuropathol
; 137(1): 121, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30328509
3.
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
Acta Neuropathol
; 137(1): 103-120, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30225556
4.
Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading.
Proc Natl Acad Sci U S A
; 113(9): E1206-15, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26884195
5.
Nanobodies raised against monomeric É-synuclein inhibit fibril formation and destabilize toxic oligomeric species.
BMC Biol
; 15(1): 57, 2017 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28673288
6.
A simple assessment model to quantifying the dynamic hippocampal neurogenic process in the adult mammalian brain.
Hippocampus
; 26(4): 517-29, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26443687
7.
Prediction of mechanistic subtypes of Parkinson's using patient-derived stem cell models.
Nat Mach Intell
; 5(8): 933-946, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615030
8.
Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity.
Nat Neurosci
; 25(9): 1134-1148, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36042314
9.
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson's disease in midbrain dopaminergic neurons.
NPJ Parkinsons Dis
; 8(1): 162, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36424392
10.
Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death.
Commun Biol
; 3(1): 79, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071389
11.
Correction: Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation.
Cell Death Differ
; 27(9): 2747, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409771
12.
Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation.
Cell Death Differ
; 27(10): 2781-2796, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32341450
13.
Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.
FEBS J
; 285(19): 3631-3644, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29924502
14.
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease.
Nat Commun
; 9(1): 2293, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895861
15.
Author Correction: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity.
Nat Neurosci
; 25(11): 1582, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261654
16.
Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synuclein.
Sci Rep
; 6: 33928, 2016 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27671749
17.
Correction: Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation.
Cell Death Differ
; 28(5): 1755, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33041329